FDA Global Panel Focuses On Developing Countries’ Reg Systems
This article was originally published in The Tan Sheet
An FDA Science Board subcommittee will assess safety awareness in countries exporting food and medical products to the U.S., and identifies promising approaches to strengthening regulatory systems in those countries, says Chairman Jeff Bender.
You may also be interested in...
The recently passed user fee reauthorization includes a provision that directs FDA to evaluate nano-engineered products’ potential benefits and safety. Friends of the Earth says nanotech products are available “prematurely … without having enough safety data.”
In a report on how FDA, industry and other stakeholders can strengthen food and drug regulatory systems abroad, the Institute of Medicine recommends the agency provide incentives for foreign regulators to meet U.S. standards and facilitate training and for the government to help hold importers liable.
Former CMS coverage director Louis Jacques talks about the strong future ahead he envisions for the Medicare coverage-with-evidence-development program and new coverage policies that will be implemented for investigational device exemption trials.